Login / Signup

Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".

Hiroshi Ito
Published in: Pharmacotherapy (2020)
Keyphrases
  • clostridium difficile
  • methicillin resistant staphylococcus aureus
  • high dose
  • early onset
  • stem cells
  • mesenchymal stem cells
  • drug induced
  • hepatitis b virus
  • bone marrow
  • smoking cessation
  • replacement therapy